Invus
Overview
Invus is a global, evergreen equity investment firm founded in 1985 that manages over $10 billion. It partners with entrepreneurs and management teams to transform their industries. The firm's capital originates from a European family group, and it does not raise outside funds, allowing for a long-term investment horizon. Invus invests across various stages, including venture capital, growth/expansion, and private equity buyouts, in sectors such as consumer goods and services, biotech, medical devices, and software.
Portfolio Companies
118
Website
invus.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Soufflé Therapeutics | Oct 2026 | Series B | Co-investor |
| Universal Quantum | Oct 2026 | Series A | Co-investor |
| Matchpoint Therapeutics | Oct 2026 | Series B | Co-investor |
| Precision Neuroscience | Sep 2026 | Series D | Co-investor |
| Caspian Therapeutics, Inc. | Sep 2026 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Julien Miara
Managing Director at Invus
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Invus based?
Invus is headquartered in New York City, New York, United States.
When was Invus founded?
Founding year information for Invus is not publicly available.
How many portfolio companies does Invus have?
Invus has 118 portfolio companies in Caplight's dataset.
What are some companies in Invus's portfolio?
Recent investments visible on Caplight include Soufflé Therapeutics, Universal Quantum, Matchpoint Therapeutics, Precision Neuroscience, Caspian Therapeutics, Inc..
What was Invus's most recent investment?
Invus's most recent investment on Caplight was in Soufflé Therapeutics in 2026.
What sectors does Invus focus on?
Invus focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, FinTech, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Consumer & Commerce, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Enterprise Software, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Enterprise Software, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Consumer & Commerce, Enterprise Software, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Enterprise Software, Consumer & Commerce, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, FinTech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Energy & Sustainability, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Consumer & Commerce, Energy & Sustainability, Consumer & Commerce, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does Invus focus on?
Invus typically invests at the Mid stage.
What is Invus's AUM?
Invus's assets under management are estimated at over $10.0B.